Evidence map›Paper›PMID 39742289›Full record

ArticleMediators of inflammation2024

Inhibiting Tyrosine Kinase 2 Ameliorates Antiphospholipid Syndrome Nephropathy.

Kuo-Tung Tang, Yu-Sin Chen, Tzu-Ting Chen, Ya-Hsuan Chao, Shu-Ping Kung, Der-Yuan Chen, Chi-Chien Lin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Mediators of inflammation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Antiphospholipid Syndrome and the Kidney.Kidney international reports · 2025
    Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kuo-Tung TangDivision of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan.ORCID https://orcid.org/0000-0002-5468-1329
Yu-Sin ChenGraduate Institute of Biotechnology, National Chung Hsing University, Taichung, Taiwan.
Tzu-Ting ChenInstitute of Bioinformatics and Structural Biology and Department of Medical Science, National Tsing Hua University, Hsinchu, Taiwan.
Ya-Hsuan ChaoInstitute of Biomedical Science, The iEGG and Animal Biotechnology Center, National Chung-Hsing University, Taichung, Taiwan.
Shu-Ping KungInstitute of Biomedical Science, The iEGG and Animal Biotechnology Center, National Chung-Hsing University, Taichung, Taiwan.
Der-Yuan ChenRheumatology and Immunology Center, China Medical University Hospital, Taichung, Taiwan.ORCID https://orcid.org/0000-0003-1266-1423
Chi-Chien LinProgram in Translational Medicine, National Chung Hsing University, Taichung, Taiwan.ORCID https://orcid.org/0000-0002-1464-0231

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiphospholipid SyndromeMice, Inbred BALB CTYK2 KinaseAnimalsBlood Urea NitrogenDisease Models, AnimalFemaleImmunohistochemistryInterferon Type IKidneyKidney DiseasesMaleMiceReal-Time Polymerase Chain ReactionInterferon Type ITYK2 Kinaseantiphospholipid antibody syndromenephropathythrombotic microangiopathytype I interferontyrosine kinase 2

Identifiers

PMID39742289
PMCPMC11688129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.